Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis

Rheumatology International

Volumn 26, Issue 1, 2005, Pages 80-82

  Düzgün, Nurşen ^a   Morris, Yonca ^a   Güllü, Sevim ^a   Gürsoy, Alptekin ^a   Ensari, Arzu ^a   Kumbasar, Özlem Özdemir ^a   Duman, Murat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

ANCA; Arthritis; Diabetes insipidus; Wegener granulomatosis

Indexed keywords

ADENOHYPOPHYSIS HORMONE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIABETES INSIPIDUS; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DOSE RESPONSE; DRUG PULSE THERAPY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; LUNG DISEASE; LUNG NODULE; NEUROHYPOPHYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYARTHRITIS; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; TREATMENT OUTCOME; URINE SEDIMENT; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COIN LESION, PULMONARY; DIABETES INSIPIDUS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS; HUMANS; MAGNETIC RESONANCE IMAGING; METHOTREXATE; MIDDLE AGED; PITUITARY GLAND, POSTERIOR; PREDNISONE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 27444441659     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0583-0     Document Type: Article

References (13)

1. Jenette JC, Falk RJ, Andrassy K, Bacon PA et al (1994) Nomenclature of syndrome vasculitides: the proposal of an international consensus conference. Arthritis Rheum 37:187-192
2. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW et al (1992) Wegener's granulomatosis; an analysis of 158 patients. Ann Intern Med 116:488-498
3. Hurst NP, Dunn NA, Chalmers TM (1983) Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis 42:600-660
4. Nishino H, Rubino F, DeRemee RA, Swanson JW et al (1993) Neurological involvement in Wegener granulomatosis: analysis of 324 consecutive patients at Mayo Clinic. Ann Neurol 33:4-9
5. Rosete A, Cabral AR, Kraus A, Alarcon-Segovia D (1991) Diabetes insipidus secondary to Wegener's granulomatosis: report and review of the literature. J Rheumatol 18:761-765
6. Garovic VD, Clark BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener's granulomatosis. Am J Kidney Dis 37(1):E5
7. Berthier S, Gil H, Bonneville JF, Magy N, De Wazieres B, Mallet H, Dupond JL (2000) Wegener's disease and central diabetes insipidus. Ann Endocrinol (Paris) 61:531-537
8. Roberts GA, Erin A, Sinclair H, Pelling M et al (1995) Two cases of Wegener's granulomatosis involving the pituitary. Clin Endocrinol 42:325-328
9. Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener's granulomatosis: a report of two cases. Am J Neuroradiol 20:519-570
10. Czarnecki EJ, Spickler EM (1995) Magnetic resonance demonstration of Wegener granulomatosis of the infindibulum, a case of diabetes insipidus. AJNR Am J Neuroradiol 16(4 Supp I):968-70
11. Goebel R, Jakse R, Passath A, Michalmayr G (1982) Wegener granulomatosis causing diabetes insipidus. Fortschr Med 100:1400-1402
12. Haynes BF, Fauci AS (1978) Diabetes Insipidus associated with Wegener's granulomatosis successfully treated with cyclophosphamide. N Engl J Med 299:764
13. Miesen WMAJ, Janssens ENW, van Bommel EFH (1999) Diabetes insipidus as the presenting symptom of Wegener's granulomatosis. Nephrol Dial Transplant 14:426-429